369 related articles for article (PubMed ID: 27781558)
1. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
Karamanidou T; Bourganis V; Kammona O; Kiparissides C
Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Suchaoin W; Bernkop-Schnürch A
Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
[TBL] [Abstract][Full Text] [Related]
4. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
5. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
Okur NÜ; Siafaka PI; Gökçe EH
Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
[TBL] [Abstract][Full Text] [Related]
6. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
7. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
8. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
Silva AC; Santos D; Ferreira D; Lopes CM
Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
12. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
[TBL] [Abstract][Full Text] [Related]
15. Lipid-based nanosuspensions for oral delivery of peptides, a critical review.
Dumont C; Bourgeois S; Fessi H; Jannin V
Int J Pharm; 2018 Apr; 541(1-2):117-135. PubMed ID: 29476783
[TBL] [Abstract][Full Text] [Related]
16. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
[TBL] [Abstract][Full Text] [Related]
17. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
18. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
Nabi B; Rehman S; Baboota S; Ali J
AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
[TBL] [Abstract][Full Text] [Related]
19. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.
Elnaggar YSR; Omran S; Hazzah HA; Abdallah OY
Int J Pharm; 2019 Jun; 564():410-425. PubMed ID: 31029657
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
